PAVSParanovus Entertainment Technology Ltd.
The Read
PAVS's stock historically dropped 85% on its June 10 earnings due to a $10 million dilutive offering overshadowing positive developments, then fell 35%.
The schedule
- Thu15Oct
Strategic update on PAVS's functional foods expansion and product pipeline commercialization.
- Sun1Nov
Impact of the Trump administration's trade and tariff policies on PAVS's cross-border supply chain and functional food ingredients.
- Tue24Nov
- Tue15Dec
PAVS's full-year FY26 results highlighting net income trajectory, cash burn, and forward guidance into 2027.
Past
- Mon31Aug
Anticipated capital raise or dilutive equity financing to extend PAVS's cash runway.
- Tue30Jun
Actual outcome: Bear · $4.78 at outcome
Paranovus Entertainment Technology executed a 1-for-100 reverse stock split on June 29, 2026, just ahead of its Nasdaq minimum bid-price compliance deadline. While the split mechanically raised the share price to regain compliance, the stock subsequently fell 35.7% by the outcome date, reflecting severe investor skepticism and the continued downward pressure typical of such massive reverse splits.
Final Nasdaq minimum bid-price compliance window for PAVS, heavily influenced by the recent reverse stock split mechanics.
- Wed10Jun
Actual outcome: Bear · $5.60 at outcome
Paranovus reported in-line EPS for the quarter, but the stock collapsed following the announcement of a highly dilutive $10 million registered direct offering of 50 million shares and pre-funded warrants. While the company also signed a non-binding LOI to acquire Jabanero Inc. and terminated its prior at-the-market offering agreement, the severe dilution from the new capital raise completely overshadowed these developments and drove shares down over 85%.
FY26 Q2 results and outlook will show whether Paranovus is sustaining the sharp rebound in revenue while narrowing heavy losses, setting the near-term trading range around $1.71 into a potential re-rating toward $3.00 or a breakdown toward $3.00.
